These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16673615)

  • 1. Dysphagia as a primary manifestation of hyperthyroidism: a case report.
    Guldiken B; Guldiken SS; Turgut N; Yuce M; Arikan E; Tugrul A
    Acta Clin Belg; 2006; 61(1):35-7. PubMed ID: 16673615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotoxicosis presenting as acute bulbar palsy.
    Mathew B; Devasia AJ; Ayyar V; Thyagaraj V; Francis GA
    J Assoc Physicians India; 2011 Jun; 59():386-7. PubMed ID: 21751598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rising serum thyroxine levels and chorea in graves' disease.
    Leblicq C; Duval M; Carmant L; Van Vliet G; Alos N
    Pediatrics; 2013 Feb; 131(2):e616-9. PubMed ID: 23296438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Graves' disease--antithyroid drug therapy].
    Onaya T
    Nihon Rinsho; 1999 Aug; 57(8):1846-50. PubMed ID: 10483263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Graves' disease.
    Ginsberg J
    CMAJ; 2003 Mar; 168(5):575-85. PubMed ID: 12615754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report of Graves' disease manifesting with odynophagia and heartburn.
    Evsyutina Y; Trukhmanov A; Ivashkin V; Storonova O; Godjello E
    World J Gastroenterol; 2015 Dec; 21(48):13582-6. PubMed ID: 26730171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of thyrotoxicosis associated with Graves' disease.
    Mazzaferri EL
    Med Times; 1972 Aug; 100(8):47-61 passim. PubMed ID: 4114172
    [No Abstract]   [Full Text] [Related]  

  • 13. New-onset Graves' disease in the postpartum period.
    Goldstein AL
    J Midwifery Womens Health; 2013; 58(2):211-4. PubMed ID: 23590488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
    Glaser NS; Styne DM;
    Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid storm after coronary artery bypass grafting.
    Bish LT; Bavaria JE; Augoustides J
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):e67-9. PubMed ID: 20692002
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
    Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysphagia as a primary manifestation of hyperthyroidism.
    Branski D; Levy J; Globus M; Aviad I; Keren A; Chowers I
    J Clin Gastroenterol; 1984 Oct; 6(5):437-40. PubMed ID: 6501830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.